Division of Nephrology and Hypertension, Hofstra North Shore-LIJ School of Medicine, Great Neck, New York, USA.
Clin J Am Soc Nephrol. 2011 May;6(5):960-5. doi: 10.2215/CJN.10101110. Epub 2011 Mar 24.
Severe hyponatremia (<120 mEq/L) in hospitalized patients has a high mortality rate. We hypothesized that underlying diseases causing hyponatremia attribute to mortality rather than hyponatremia itself.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The relationship between mortality and serum sodium (sNa) was examined in 45,693 patients admitted to a single community teaching hospital between January 1996 and December 2007. We conducted a comprehensive retrospective review of the medical records of 53 patients who died after developing sNa <120 mEq/L before or after admission and of 32 patients who survived after developing sNa <110 mEq/L.
Mortality rates tended to increase as the sNa fell from 134 to 120 mEq/L, rising above 10% for patients with sNa of 120 to 124 mEq/L. However, below sNa of 120 mEq/L, the trend reversed, such that the mortality rate progressively decreased as sNa fell. More than two thirds of patients who died after sNa <120 mEq/L had at least two additional acute severe progressive illnesses, most commonly sepsis and multiorgan failure. Three deaths (5.6%) in 12 years could plausibly be related to adverse consequences of hyponatremia, and one (1.8% of the fatal cases and 0.15% of all patients with sNa <120 mEq/L) was from cerebral edema. Most patients who survived with sNa <110 mEq/L had medication-induced hyponatremia. Severe underlying illnesses were uncommon in this group.
The nature of underlying illness rather than the severity of hyponatremia best explains mortality associated with hyponatremia. Neurologic complications from hyponatremia are uncommon among patients who die with hyponatremia.
住院患者发生严重低钠血症(<120mEq/L)具有较高的死亡率。我们推测导致低钠血症的基础疾病是导致死亡的原因,而非低钠血症本身。
设计、地点、参与者和测量方法:本研究在 1996 年 1 月至 2007 年 12 月期间,对一家社区教学医院收治的 45693 例患者的死亡率与血清钠(sNa)之间的关系进行了研究。我们对 53 例在入院前或入院后 sNa<120mEq/L 时死亡的患者的病历进行了全面的回顾性分析,同时对 32 例在 sNa<110mEq/L 时存活的患者的病历进行了回顾性分析。
随着 sNa 从 134mEq/L 降至 120mEq/L,死亡率呈上升趋势,当 sNa 为 120~124mEq/L 时,死亡率超过 10%。然而,当 sNa<120mEq/L 时,这种趋势发生逆转,sNa 下降时死亡率逐渐降低。sNa<120mEq/L 后死亡的患者中,超过三分之二至少患有另外两种急性严重进行性疾病,最常见的是脓毒症和多器官功能衰竭。在 12 年中有 3 例(5.6%)死亡可能与低钠血症的不良后果有关,其中 1 例(致命病例的 1.8%和 sNa<120mEq/L 患者的 0.15%)死于脑水肿。大多数 sNa<110mEq/L 存活的患者存在药物诱导性低钠血症。该组患者中严重基础疾病并不常见。
基础疾病的性质而非低钠血症的严重程度是导致低钠血症相关死亡率的最佳解释。低钠血症导致死亡的患者中,神经并发症并不常见。